Medicines Company to be Acquired by Novartis AG for $9.7 Billion
Novartis AG will acquire The Medicines Company for $85 per share in an all-cash transaction, implying a fully diluted equity value of $9.7 billion. The price represents a premium of approximately 45% to The Medicines […]
Medicines Company to be Acquired by Novartis AG for $9.7 Billion Read More »